. . . . . "3.09655E9"^^ . "6.146954E9"^^ . . "about 6,000"@en . "US $6,146,954,000"@en . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2251.0"^^ . . . . . "US $630.1 million"@en . "QIAGEN N.V."@en . "Qiagen"@ru . . "QIAGEN (NYSE : QGEN, FWB : QIA) est une soci\u00E9t\u00E9 qui vend des kits de biologie mol\u00E9culaire. Ces produits sont destin\u00E9s \u00E0 la pr\u00E9paration d'\u00E9chantillon en pr\u00E9analyse et des solutions de . Fond\u00E9 en 1984, QIAGEN N.V. est maintenant une compagnie de holding n\u00E9erlandaise avec un centre op\u00E9rationnel bas\u00E9 \u00E0 Hilden en Allemagne. Qiagen poss\u00E8de des filiales dans 14 pays et emploie environ 5200 personnes \u00E0 travers le monde."@fr . . . . . . . . . . . . . . . . . . . . . . . "US $3,096,550,000"@en . . . . . . . "1"^^ . . . . . "30728"^^ . . . "La QIAGEN \u00E8 un produttore di tecnologie per campioni e analisi per la test applicati, per la ricerca accademica e farmaceutica. Consolidata sotto la holding olandese QIAGEN NV, la societ\u00E0 gestisce pi\u00F9 di 35 uffici in oltre 25 paesi. Le azioni di QIAGEN sono quotate al NYSE (con il ticker QGEN) e alla Borsa di Francoforte nel Prime Standard (con il ticker QIA).La sede operativa principale si trova a Hilden, in Germania; Thierry Bernard \u00E8 l'amministratore delegato dell'azienda."@it . . . . "1984-11-29"^^ . . . "Die Qiagen N.V. (eigene Schreibweise: QIAGEN) mit Sitz in Venlo und operativer Zentrale in Hilden bei D\u00FCsseldorf ist ein b\u00F6rsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien f\u00FCr die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 L\u00E4ndern."@de . "Metin Colpan, Karsten Henco, J\u00FCrgen Schumacher"@en . . . "center"@en . "\u30AD\u30A2\u30B2\u30F3"@ja . . . . . . "Thierry Bernard ( ), Lawrence A. Rosen"@en . . "Qiagen (\u041A\u0430\u0439\u0430\u0433\u0435\u043D, NASDAQ: QGEN, FWB: QIA) \u2014 \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F, \u0440\u0430\u0437\u0440\u0430\u0431\u0430\u0442\u044B\u0432\u0430\u044E\u0449\u0430\u044F \u0438 \u043F\u0440\u043E\u0438\u0437\u0432\u043E\u0434\u044F\u0449\u0430\u044F \u043E\u0431\u043E\u0440\u0443\u0434\u043E\u0432\u0430\u043D\u0438\u0435 \u0438 \u0440\u0430\u0441\u0445\u043E\u0434\u043D\u044B\u0435 \u043C\u0430\u0442\u0435\u0440\u0438\u0430\u043B\u044B \u0434\u043B\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u043E\u0439 \u0434\u0438\u0430\u0433\u043D\u043E\u0441\u0442\u0438\u043A\u0438, \u043D\u0430\u0443\u0447\u043D\u044B\u0445 \u0438 \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0445 \u0438\u0441\u0441\u043B\u0435\u0434\u043E\u0432\u0430\u043D\u0438\u0439. \u0412 \u0433\u043E\u043B\u043B\u0430\u043D\u0434\u0441\u043A\u0438\u0439 \u0445\u043E\u043B\u0434\u0438\u043D\u0433 Qiagen N.V. \u0432\u0445\u043E\u0434\u0438\u0442 \u0431\u043E\u043B\u0435\u0435 30 \u0434\u043E\u0447\u0435\u0440\u043D\u0438\u0445 \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u0439 \u043F\u043E \u0432\u0441\u0435\u043C\u0443 \u043C\u0438\u0440\u0443. \u0410\u043A\u0446\u0438\u0438 Qiagen \u043A\u043E\u0442\u0438\u0440\u0443\u044E\u0442\u0441\u044F \u043D\u0430 \u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0447\u0435\u0441\u043A\u043E\u0439 \u0431\u0438\u0440\u0436\u0435 \u0421\u0428\u0410 Nasdaq (QGEN) \u0438 \u043D\u0430 \u0424\u0440\u0430\u043D\u043A\u0444\u0443\u0440\u0442\u0441\u043A\u043E\u0439 \u0444\u043E\u043D\u0434\u043E\u0432\u043E\u0439 \u0431\u0438\u0440\u0436\u0435 (QIA). \u0413\u043B\u0430\u0432\u043D\u044B\u043C \u0438\u0441\u043F\u043E\u043B\u043D\u0438\u0442\u0435\u043B\u044C\u043D\u044B\u043C \u0434\u0438\u0440\u0435\u043A\u0442\u043E\u0440\u043E\u043C \u044F\u0432\u043B\u044F\u0435\u0442\u0441\u044F Peer M. Schatz. \u0428\u0442\u0430\u0431-\u043A\u0432\u0430\u0440\u0442\u0438\u0440\u0430 \u0440\u0430\u0441\u043F\u043E\u043B\u0430\u0433\u0430\u0435\u0442\u0441\u044F \u0432 \u0425\u0438\u043B\u044C\u0434\u0435\u043D\u0435, \u0413\u0435\u0440\u043C\u0430\u043D\u0438\u044F, \u0431\u043B\u0438\u0437 \u0414\u044E\u0441\u0441\u0435\u043B\u044C\u0434\u043E\u0440\u0444\u0430."@ru . . . "Die Qiagen N.V. (eigene Schreibweise: QIAGEN) mit Sitz in Venlo und operativer Zentrale in Hilden bei D\u00FCsseldorf ist ein b\u00F6rsennotierter Anbieter von Probenvorbereitungs- und Testtechnologien f\u00FCr die molekulare Diagnostik, akademische Forschung, pharmazeutische Industrie und angewandte Testverfahren mit Standorten in mehr als 25 L\u00E4ndern."@de . . "QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany."@en . "\u30AD\u30A2\u30B2\u30F3\uFF08QIAGEN N.V.\uFF09\u306F\u3001DNA\u3001RNA\u3084\u30BF\u30F3\u30D1\u30AF\u8CEA\u306E\u751F\u4F53\u304B\u3089\u306E\u62BD\u51FA\u30FB\u89E3\u6790\u306A\u3069\u306B\u95A2\u9023\u3059\u308B\u8A66\u85AC\u30FB\u4F53\u5916\u8A3A\u65AD\u85AC\u304A\u3088\u3073\u5206\u5B50\u8A3A\u65AD\u6A5F\u5668\u3092\u63D0\u4F9B\u3059\u308B\u30D0\u30A4\u30AA\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u4F01\u696D\u3002\u672C\u793E\u3092\u30AA\u30E9\u30F3\u30C0\u30FB\u30D5\u30A7\u30F3\u30ED\u30FC\u306B\u3001\u30AA\u30DA\u30EC\u30FC\u30B7\u30E7\u30F3\u672C\u90E8\u3092\u30C9\u30A4\u30C4\u30FB\u30CE\u30EB\u30C8\u30E9\u30A4\u30F3\uFF1D\u30F4\u30A7\u30B9\u30C8\u30D5\u30A1\u30FC\u30EC\u30F3\u5DDE\u30FBHilden\u306B\u7F6E\u304D\u3001\u4E16\u754C25\u30AB\u56FD\u4EE5\u4E0A\u306B\u73FE\u5730\u6CD5\u4EBA\u3092\u6301\u3064\u3002\u30D5\u30E9\u30F3\u30AF\u30D5\u30EB\u30C8\u8A3C\u5238\u53D6\u5F15\u6240\u304A\u3088\u3073\u30CB\u30E5\u30FC\u30E8\u30FC\u30AF\u8A3C\u5238\u53D6\u5F15\u6240\u306B\u4E0A\u5834\u3057\u3066\u3044\u308B\uFF08FWB: QIA\u3001NYSE: QGEN\uFF09\u3002"@ja . . . "Qiagen"@fr . . "QIAGEN (NYSE : QGEN, FWB : QIA) est une soci\u00E9t\u00E9 qui vend des kits de biologie mol\u00E9culaire. Ces produits sont destin\u00E9s \u00E0 la pr\u00E9paration d'\u00E9chantillon en pr\u00E9analyse et des solutions de . Fond\u00E9 en 1984, QIAGEN N.V. est maintenant une compagnie de holding n\u00E9erlandaise avec un centre op\u00E9rationnel bas\u00E9 \u00E0 Hilden en Allemagne. Qiagen poss\u00E8de des filiales dans 14 pays et emploie environ 5200 personnes \u00E0 travers le monde."@fr . "Qiagen Acquisitions"@en . "1984-11-29"^^ . . . "La QIAGEN \u00E8 un produttore di tecnologie per campioni e analisi per la test applicati, per la ricerca accademica e farmaceutica. Consolidata sotto la holding olandese QIAGEN NV, la societ\u00E0 gestisce pi\u00F9 di 35 uffici in oltre 25 paesi. Le azioni di QIAGEN sono quotate al NYSE (con il ticker QGEN) e alla Borsa di Francoforte nel Prime Standard (con il ticker QIA).La sede operativa principale si trova a Hilden, in Germania; Thierry Bernard \u00E8 l'amministratore delegato dell'azienda."@it . "1984"^^ . . . . . . . . . "Qiagen"@de . . . . . . . . . "QIAGEN is a German provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Consolidated under the Dutch holding QIAGEN N.V., the company operates more than 35 offices in over 25 countries. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer. The main operative headquarters are located in Hilden, Germany."@en . . "NYSE:QGEN"@en . "130"^^ . . . "\u30AD\u30A2\u30B2\u30F3\uFF08QIAGEN N.V.\uFF09\u306F\u3001DNA\u3001RNA\u3084\u30BF\u30F3\u30D1\u30AF\u8CEA\u306E\u751F\u4F53\u304B\u3089\u306E\u62BD\u51FA\u30FB\u89E3\u6790\u306A\u3069\u306B\u95A2\u9023\u3059\u308B\u8A66\u85AC\u30FB\u4F53\u5916\u8A3A\u65AD\u85AC\u304A\u3088\u3073\u5206\u5B50\u8A3A\u65AD\u6A5F\u5668\u3092\u63D0\u4F9B\u3059\u308B\u30D0\u30A4\u30AA\u30C6\u30AF\u30CE\u30ED\u30B8\u30FC\u4F01\u696D\u3002\u672C\u793E\u3092\u30AA\u30E9\u30F3\u30C0\u30FB\u30D5\u30A7\u30F3\u30ED\u30FC\u306B\u3001\u30AA\u30DA\u30EC\u30FC\u30B7\u30E7\u30F3\u672C\u90E8\u3092\u30C9\u30A4\u30C4\u30FB\u30CE\u30EB\u30C8\u30E9\u30A4\u30F3\uFF1D\u30F4\u30A7\u30B9\u30C8\u30D5\u30A1\u30FC\u30EC\u30F3\u5DDE\u30FBHilden\u306B\u7F6E\u304D\u3001\u4E16\u754C25\u30AB\u56FD\u4EE5\u4E0A\u306B\u73FE\u5730\u6CD5\u4EBA\u3092\u6301\u3064\u3002\u30D5\u30E9\u30F3\u30AF\u30D5\u30EB\u30C8\u8A3C\u5238\u53D6\u5F15\u6240\u304A\u3088\u3073\u30CB\u30E5\u30FC\u30E8\u30FC\u30AF\u8A3C\u5238\u53D6\u5F15\u6240\u306B\u4E0A\u5834\u3057\u3066\u3044\u308B\uFF08FWB: QIA\u3001NYSE: QGEN\uFF09\u3002"@ja . . . "1105684829"^^ . . . . . . . . . . "US $2,251.7 million"@en . "6000"^^ . . . . . . . . . . . "Qiagen"@en . . . . "FWB:QIA"@en . . . . . . . . . "Qiagen"@it . "3283783"^^ . . "6.301E8"^^ . . . . "Qiagen (\u041A\u0430\u0439\u0430\u0433\u0435\u043D, NASDAQ: QGEN, FWB: QIA) \u2014 \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F, \u0440\u0430\u0437\u0440\u0430\u0431\u0430\u0442\u044B\u0432\u0430\u044E\u0449\u0430\u044F \u0438 \u043F\u0440\u043E\u0438\u0437\u0432\u043E\u0434\u044F\u0449\u0430\u044F \u043E\u0431\u043E\u0440\u0443\u0434\u043E\u0432\u0430\u043D\u0438\u0435 \u0438 \u0440\u0430\u0441\u0445\u043E\u0434\u043D\u044B\u0435 \u043C\u0430\u0442\u0435\u0440\u0438\u0430\u043B\u044B \u0434\u043B\u044F \u043C\u043E\u043B\u0435\u043A\u0443\u043B\u044F\u0440\u043D\u043E\u0439 \u0434\u0438\u0430\u0433\u043D\u043E\u0441\u0442\u0438\u043A\u0438, \u043D\u0430\u0443\u0447\u043D\u044B\u0445 \u0438 \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0438\u0445 \u0438\u0441\u0441\u043B\u0435\u0434\u043E\u0432\u0430\u043D\u0438\u0439. \u0412 \u0433\u043E\u043B\u043B\u0430\u043D\u0434\u0441\u043A\u0438\u0439 \u0445\u043E\u043B\u0434\u0438\u043D\u0433 Qiagen N.V. \u0432\u0445\u043E\u0434\u0438\u0442 \u0431\u043E\u043B\u0435\u0435 30 \u0434\u043E\u0447\u0435\u0440\u043D\u0438\u0445 \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u0439 \u043F\u043E \u0432\u0441\u0435\u043C\u0443 \u043C\u0438\u0440\u0443. \u0410\u043A\u0446\u0438\u0438 Qiagen \u043A\u043E\u0442\u0438\u0440\u0443\u044E\u0442\u0441\u044F \u043D\u0430 \u0442\u0435\u0445\u043D\u043E\u043B\u043E\u0433\u0438\u0447\u0435\u0441\u043A\u043E\u0439 \u0431\u0438\u0440\u0436\u0435 \u0421\u0428\u0410 Nasdaq (QGEN) \u0438 \u043D\u0430 \u0424\u0440\u0430\u043D\u043A\u0444\u0443\u0440\u0442\u0441\u043A\u043E\u0439 \u0444\u043E\u043D\u0434\u043E\u0432\u043E\u0439 \u0431\u0438\u0440\u0436\u0435 (QIA). \u0413\u043B\u0430\u0432\u043D\u044B\u043C \u0438\u0441\u043F\u043E\u043B\u043D\u0438\u0442\u0435\u043B\u044C\u043D\u044B\u043C \u0434\u0438\u0440\u0435\u043A\u0442\u043E\u0440\u043E\u043C \u044F\u0432\u043B\u044F\u0435\u0442\u0441\u044F Peer M. Schatz. \u0428\u0442\u0430\u0431-\u043A\u0432\u0430\u0440\u0442\u0438\u0440\u0430 \u0440\u0430\u0441\u043F\u043E\u043B\u0430\u0433\u0430\u0435\u0442\u0441\u044F \u0432 \u0425\u0438\u043B\u044C\u0434\u0435\u043D\u0435, \u0413\u0435\u0440\u043C\u0430\u043D\u0438\u044F, \u0431\u043B\u0438\u0437 \u0414\u044E\u0441\u0441\u0435\u043B\u044C\u0434\u043E\u0440\u0444\u0430."@ru . . . "QIAGEN N.V."@en . . . . . . .